Cryptococccal meningoencephalitis after H1N1 influenza

MR imaging in novel influenza A(H1N1)-associated meningoencephalitis.

MR imaging manifestations of influenza A-associated encephalitis have been described previously. However, there is very limited information about the central nervous system complications of the novel influenza A(H1N1) virus. MR imaging findings of novel influenza A-associated meningoencephalitis in a child are presented.

Influenza A(H1N1) pandemic: 2 years after.

Dear Sir, In 2009, the emergence of the new H1N1 influenza virus saw the world brace itself for the first influenza pandemic since 1968. Two years after, it is time to evaluate the situation of that Influenza A(H1N1) pandemic and its combat measures. First, alert level was raised rapidly from level 3 to level 6 in 6 weeks. On 25 April 2009, the WHO declared a level 3 Influenza Pandemic Alert. T...

2009 H1N1 Influenza Virus Seroepidemiology

Construction of Influenza A/H1N1 Virosomal Nanobioparticles

Background and Aims: Influenza is one of the main respiratory infections of humans, responsible for 300,000–500,000 annual deaths world-wide. Vaccination is one of the best ways to prevent infections including influenza. Influenza virosomes are virus-like particles, which retain the cell binding and membrane fusion properties of the native virus, but lack the ribonucleoprotein (RNP). A vi...

Risk of fatal adverse events after H1N1 influenza vaccination.

Figure 1. Number of fatal cases. Most of the fatal cases, which peaked in number within 24 h after H1N1 influenza vaccination, occurred within 4 days after vaccination. EFV levels ( ) and NVP dosage P p .008 ( ) were independently and posiP ! .001 tively associated with the steady-state plasma NVP levels in multivariate analysis. The switch from EFV to NVP can lead to a time-limited subtherapeu...